Navigation Links
ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
Date:12/9/2008

CAMBRIDGE, United Kingdom and MONTREAL, Dec. 9 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces that its U.K.-based subsidiary, ProMetic BioSciences Ltd ("PBL"), has signed a Long-term Supply Agreement (the "Agreement") with a world-leading European Biopharmaceutical company estimated to be worth up to $35 M over the next six years, with first shipment delivery starting this quarter. This Agreement will provide access to one of ProMetic's proprietary affinity adsorbents for incorporation into this company's manufacturing process.

"This agreement provides further evidence of the underlying growth in the demand for ProMetic's proprietary affinity adsorbents," commented Dr. Steve Burton, PBL's Chief Executive Officer. Dr. Burton added: "Due to reasons of client confidentiality the terms of the Agreement and the name of ProMetic's partner remain undisclosed."

"More and more biopharmaceutical products that have received or are expecting to receive approval from the regulatory agencies such as the Food and Drug Administration or the European Medicines Agency are now manufactured using ProMetic's affinity adsorbent products," stated Mr. Pierre Laurin, ProMetic's President and Chief Executive Officer. "ProMetic's affinity adsorbent products are therefore locked into the regulated manufacturing processes of these biopharmaceuticals and represent long-term recurring and growing annuity revenues for the Company," concluded Mr. Laurin.

About ProMetic BioSciences Ltd

Using its unique and proprietary Mimetic Ligand(TM) technology, ProMetic BioSciences Ltd ("PBL") specializes in the development and manufacture of robust affinity separation materials which provide very high levels of purification. This is achieved by use of small chemical affinity ligands designed to bind a target biomolecule specifically and reversibly. In view of their use for the production of therapeutics, ProM
'/>"/>

SOURCE Prometic Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ProMetic to present at Merriman Curhan Fords Investor Summit 2008 on September 16th
2. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
3. ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference
4. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
5. Prometic provides information for its Annual and Special Meeting of Shareholders
6. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
7. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
8. Prometic to present at the American Chemical Society
9. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
10. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
11. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 Mapp ... experimental ZMapp™ antibody therapeutic to fight the Ebola ... difficult and time-consuming the production of pharmaceuticals can ... research publisher said that while some may be ... this compound, those with industry knowledge are well ...
(Date:10/20/2014)... ON , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: ... $1.7 million which brings Q3 orders to $5.8 million and provides ... control projects in North America and one ... continue to bid new projects at record levels," said Peter ... were higher at the end of Q3 than they have been ...
(Date:10/20/2014)... 20, 2014 PureTech , a science ... healthcare problems, announced today the closing of a ... from Invesco Perpetual, a $120 Billion group of ... PureTech,s existing pipeline forward and to advance new ... scientific creativity to really go for the big ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Local veterinary ... in an investigational study of donor stem cells for ... stem cell therapy and has performed clinical stem cell ... study is to determine if a single injection of ... joints can help reduce pain and inflammation in the ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... of heterologous proteins , Carsten-Peter Carstens ... , Codon bias is a significant obstacle for ... In GC-rich genomes, such as mammals,rare arginine codons ... most frequently,affect bacterial gene expression. For such situations, ...
... TaqPlus Precision PCR system, developed for,highfidelity PCR , ... Bai * Daniel McMullan,* Barbara McGowan * Holly Hogrefe ... addition of the TaqPlus Precision PCR system,* to an ... system,consists of a novel mixture of Taq2000 and Pfu ...
... , High-level expression of difficult heterologous proteins ... has created variants of the Epicurian Coli ... of strains, which contain extra copies of the E. ... for a high-level,expression of proteins that are difficult to ...
Cached Biology Technology:New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 2New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 3New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 4High-Fidelity PCR with a Novel Polymerase Mixture 2High-Fidelity PCR with a Novel Polymerase Mixture 3High-Fidelity PCR with a Novel Polymerase Mixture 4High-Fidelity PCR with a Novel Polymerase Mixture 5High-Fidelity PCR with a Novel Polymerase Mixture 6High-Fidelity PCR with a Novel Polymerase Mixture 7High-Fidelity PCR with a Novel Polymerase Mixture 8High-Fidelity PCR with a Novel Polymerase Mixture 9High-Fidelity PCR with a Novel Polymerase Mixture 10High-Fidelity PCR with a Novel Polymerase Mixture 11Codon Bias-Adjusted BL21 Derivatives for Protein Expression 2Codon Bias-Adjusted BL21 Derivatives for Protein Expression 3Codon Bias-Adjusted BL21 Derivatives for Protein Expression 4Codon Bias-Adjusted BL21 Derivatives for Protein Expression 5Codon Bias-Adjusted BL21 Derivatives for Protein Expression 6Codon Bias-Adjusted BL21 Derivatives for Protein Expression 7
(Date:10/22/2014)... identity analyst firm Acuity Market Intelligence forecasts that in ... have a chip-based National eID card, including near-complete regional ... Asia , with its vast population, is expected ... of all National eID cards issued between 2014 and ... National eID Industry Report: 2014 Edition" — projects ...
(Date:10/19/2014)... over the last 30 years contributed only marginally ... that time, according to a new study published ... "Energy access is fundamental to development: it brings ... communication, and health," says IIASA researcher Shonali Pachauri, ... access is widely agreed to be an important ...
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2Whole-exome sequencing shows potential as diagnostic tool 2
... from a blue whale to a human being, poses ... cells in its body will die without reproducing; only ... next generation. How could the extreme degree of ... all creatures unicellular individualists determined to pass on their ...
... Shenzhen, China BGI, the world,s largest ... its first cloud computing terminal server, in China ... for users without bioinformatics background and it allows ... in their own laboratories with the advantages of ...
... NL -- Parkinson,s disease is marked by the abnormal ... neurons in the substantia nigra region of the brain. ... as NACP-Rep1 has been implicated as a risk factor ... different variants of NACP-Rep1 and its interaction with the ...
Cached Biology News:Close family ties keep microbial cheaters in check, study finds 2Close family ties keep microbial cheaters in check, study finds 3Close family ties keep microbial cheaters in check, study finds 4Close family ties keep microbial cheaters in check, study finds 5BGI-BOX terminal server debut operation in China Agricultural University 2Genetic factors can predict the progression of Parkinson's disease 2
96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
...
... Microarray Hybridization Wash Pack provides optimized ... slides. Preparation Quality Clarifier: Ready-to-use wash ... with SigmaScreen(tm) APS Coated Slides for ... Microarray Hybridization Blocking Buffer: 1L • ...
Biology Products: